LakeShore Biopharma Overview
- Year Founded
-
1994
- Status
-
Private
- Employees
-
573
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
- Investments
-
2
LakeShore Biopharma General Information
Description
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Contact Information
Website
www.lakeshorebio.comCorporate Office
- Room 32, 11th Floor Lee Ka Industrial Building
- 8 Ng Fong Street, Kln Hong Kong
- San Po Kong
- Hong Kong
Corporate Office
- Room 32, 11th Floor Lee Ka Industrial Building
- 8 Ng Fong Street, Kln Hong Kong
- San Po Kong
- Hong Kong
LakeShore Biopharma Timeline
LakeShore Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LakeShore Biopharma Comparisons
Industry
Financing
Details
LakeShore Biopharma Competitors (33)
One of LakeShore Biopharma’s 33 competitors is Brii Biosciences, a Formerly VC-backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Brii Biosciences | Formerly VC-backed | Beijing, China | ||||
| Abbisko Medicine | Formerly VC-backed | Shanghai, China | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| JW Therapeutics | Formerly VC-backed | Shanghai, China | ||||
| TME Pharma | Formerly VC-backed | Berlin, Germany |
LakeShore Biopharma Patents
LakeShore Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019143291-A1 | Method for adapting influenza viruses to vero cells | Inactive | 18-Jan-2018 | ||
| AU-2018313636-A1 | A composition for treating and/or preventing hepatitis b virus infection and the use thereof | Active | 10-Aug-2017 | ||
| AU-2018313636-B2 | A composition for treating and/or preventing hepatitis b virus infection and the use thereof | Inactive | 10-Aug-2017 | ||
| WO-2019032046-A1 | A composition for treating and/or preventing hepatitis b virus infection and the use thereof | Inactive | 10-Aug-2017 | ||
| ES-2871051-T3 | A composition comprising pic for the treatment of cancer | Active | 01-Apr-2016 | A61K31/713 |
LakeShore Biopharma Signals
LakeShore Biopharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LakeShore Biopharma Acquisitions (2)
LakeShore Biopharma’s most recent deal was a Merger/Acquisition with Summit Healthcare Acquisition for . The deal was made on 16-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Summit Healthcare Acquisition | 16-Mar-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Singapore Shenyi Pickup Biotechnology | 01-Jan-2010 | Merger/Acquisition | Drug Discovery |
LakeShore Biopharma FAQs
-
When was LakeShore Biopharma founded?
LakeShore Biopharma was founded in 1994.
-
Where is LakeShore Biopharma headquartered?
LakeShore Biopharma is headquartered in San Po Kong, Hong Kong.
-
What is the size of LakeShore Biopharma?
LakeShore Biopharma has 573 total employees.
-
What industry is LakeShore Biopharma in?
LakeShore Biopharma’s primary industry is Biotechnology.
-
Is LakeShore Biopharma a private or public company?
LakeShore Biopharma is a Private company.
-
What is the current valuation of LakeShore Biopharma?
The current valuation of LakeShore Biopharma is .
-
What is LakeShore Biopharma’s current revenue?
The current revenue for LakeShore Biopharma is .
-
How much funding has LakeShore Biopharma raised over time?
LakeShore Biopharma has raised $211M.
-
Who are LakeShore Biopharma’s investors?
Oceanpine Capital has invested in LakeShore Biopharma.
-
Who are LakeShore Biopharma’s competitors?
Brii Biosciences, Abbisko Medicine, BeOne Medicines, JW Therapeutics, and TME Pharma are some of the 33 competitors of LakeShore Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process